Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ibuprofen. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102010323A details a green Pd-catalyzed synthesis for Ibuprofen. This route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1314336A details a novel two-component resolution method for high-purity (S)-(+)-ibuprofen, offering significant cost and time advantages for pharmaceutical manufacturing supply chains.
Novel patent CN108794319A offers high-purity Brufen Impurity A synthesis with cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101104861B reveals a novel Yarrowia lipolytica lipase method for S-ibuprofen. Discover cost-effective, high-selectivity biocatalysis for pharmaceutical manufacturing.
Patent CN114195633A details a novel carbonylation route for Ibuprofen Impurity F, offering high purity without chromatography for cost-effective API manufacturing.
Patent CN87100031A reveals microbial hydrolysis for high-purity S-Naproxen. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN109665999B details a novel U-type template strategy for meta-selective C-H activation, offering cost reduction in API manufacturing and scalable routes for high-purity intermediates.
Patent CN102850204B details advanced chiral resolution for NSAIDs. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN110903189B details a cost-effective copper-catalyzed route for chiral 2-aryl propionates, offering significant supply chain advantages for NSAID intermediate manufacturing.
Patent CN110143861B reveals heavy-metal-free ibuprofen synthesis. Achieve cost reduction and supply chain stability with high-purity manufacturing capabilities.
Novel synthesis for α-deuterated methyl aryl propionic acids. Enhances metabolic stability. Reliable supplier for pharma intermediates.